Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 6 Other solid neoplasm 5 Other hematologic neoplasm 5 Gastrointestinal 4 Head & Neck 3 Breast 3 Tumor-Agnostic 2 Lymphoid 2 Dermatologic 2 Thoracic 1 Other 1 Myeloid 1 Gynecologic 1 CNS 1

Conditions

Peritoneal Neoplasms 1

Interventions

Paclitaxel 39 Specimen Handling 32 Carboplatin 32 pembrolizumab 31 Bevacizumab 24 Magnetic Resonance Spectroscopy 23 Gemcitabine 15 Biopsy 15 liposomal doxorubicin 14 olaparib 13 Cisplatin 11 Nivolumab 9 Doxorubicin 9 Topotecan 8 Taxes 8 Cyclophosphamide 8 fludarabine 7 palbociclib 6 Surveys and Questionnaires 6 Fulvestrant 6 lenvatinib 5 abemaciclib 5 X-Rays 5 Immunoglobulin G 5 Docetaxel 5 Disulfides 5 1-dodecylpyridoxal 5 trastuzumab deruxtecan 4 mirvetuximab soravtansine 4 dostarlimab 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Practice Guidelines as Topic × Gynecologic × 30 days × Clear all

NCT07001748 2026-05-15

STOPGAP II

Eastern Cooperative Oncology Group

Phase 2/3 Recruiting

Peritoneal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡